Author:
Groarke John D.,Choueiri Toni K.,Slosky David,Cheng Susan,Moslehi Javid
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference62 articles.
1. Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, et al. Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(6):632–8. doi: 10.1200/JCO.2010.31.9129 .
2. Tsai HT, Marshall JL, Weiss SR, Huang CY, Warren JL, Freedman AN, et al. Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2013;24(6):1574–9. doi: 10.1093/annonc/mdt019 .
3. Ramlau R, Gorbunova V, Ciuleanu TE, Novello S, Ozguroglu M, Goksel T, et al. Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(29):3640–7. doi: 10.1200/JCO.2012.42.6932 .
4. Chen H, Modiano MR, Neal JW, Brahmer JR, Rigas JR, Jotte RM, et al. A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer. Br J Cancer. 2013. doi: 10.1038/bjc.2013.735 .
5. Richards CJ, Je Y, Schutz FA, Heng DY, Dallabrida SM, Moslehi JJ, et al. Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(25):3450–6. doi: 10.1200/JCO.2010.34.4309 .
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献